Notice of Delisting and Re-Compliance of Nasdaq Listing Rule
- Nilfisk reports Q1 2025 results: Financial results in line with expectations – 2025 guidance maintained - May 13, 2025
- Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders - May 13, 2025
- NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Relate - May 13, 2025